Patent foramen ovale

There are 14 papers on patent foramen ovale in aging research: 11 observational studies in people, 3 reviews. The newest story, Oct 26, 2026: “Heart defects linked to more complications in artery disease”.

Disease

14 papers study it3 more mention it13 findings

5 new papers in 30 daysSee all 17 papers on patent foramen ovale

“Among 142,465 patients with OSA, the presence of a PFO was associated with a 9.04-fold higher stroke prevalence”
A Possible Synergistic Association of Obstructive Sleep Apnea and Patent Foramen Ovale on Ischemic Stroke RiskAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.16230
  • Humans11

Effects

1

Mortality

no changein humans2HR 0.99

2 studies
  1. Patent foramen ovale was not clearly linked with mortality in humans (Patients with BMI ≥35; patent foramen ovale versus no patent foramen ovale) (HR 0.99, 95% CI 0.88–1.11).

    “whereas all-cause mortality was neutral (HR 0.99, 0.88–1.11; p=0.86)”

    HumansPatients with BMI ≥35; patent foramen ovale versus no patent foramen ovale5 years

    Interplay of patent foramen ovale and severe obesity in long-term thromboembolic and cardiovascular outcomes

    ESC Congress 2026 abstract

  2. Patent foramen ovale was not clearly linked with mortality in humans (CT-detected PFO) (adjusted hazard ratio 0.96, 95% confidence interval 0.61-1.50).

    “no significant association was observed with all-cause mortality (adjusted hazard ratio 0.96, 95% confidence interval 0.61-1.50, p = 0.86)”

    HumansCT-detected PFOheartn = 1,028

    Association Between Cardiac Computed Tomography-Detected Patent Foramen Ovale and Risk of Ischemic Stroke

    The American journal of cardiology

Associations

11

Neuroimaging abnormalities

upin humans1

1 study
  1. Patent foramen ovale is associated with neuroimaging abnormalities in humans (PFO-positive patients compared with controls) (68% versus 34%; p<0.001).

    “Any neuroimaging abnormality was also more frequent in PFO-positive patients (68% vs. 34%, p<0.001).”

    HumansPFO-positive patients compared with controlsbrainn = 149

    Age-Dependent White Matter Injury in Patent Foramen Ovale: Clinical Validation of a Literature-Trained Predictive Framework

    AHA Scientific Sessions 2026 abstract

Cerebral white matter lesions

upin humans1OR 2.5

1 study
  1. Patent foramen ovale is associated with cerebral white matter lesions in humans (TTE-detected patent foramen ovale compared with controls) (54% versus 32%; OR 2.5, 95% CI 1.1–5.6).

    “Patients with PFO had a significantly higher prevalence of WMLs than controls (54% vs. 32%; OR 2.5, 95% CI 1.1-5.6, p=0.020).”

    HumansTTE-detected patent foramen ovale compared with controlscerebral white mattern = 149

    Age-Dependent White Matter Injury in Patent Foramen Ovale: Clinical Validation of a Literature-Trained Predictive Framework

    AHA Scientific Sessions 2026 abstract

More on Cerebral white matter lesions

Heart failure hospitalization

no changein humans1

1 study
  1. Patent foramen ovale is associated with heart failure hospitalization in humans (Patients with obstructive sleep apnea) (aHR 0.97, 95% CI 0.83–1.14; p=0.72).

    “PFO was independently associated with increased risks of stroke/TIA and all-cause mortality but not with MI, HF hospitalization, or composite MACE.”

    HumansPatients with obstructive sleep apneaFive years70.5% malesn = 5,963

    Association of Patent Foramen Ovale with Cardiovascular Outcomes and Mortality in Patients with Obstructive Sleep Apnea

    AHA Scientific Sessions 2026 abstract

Myocardial infarction

no changein humans1

1 study
  1. Patent foramen ovale is associated with myocardial infarction in humans (Patients with obstructive sleep apnea) (aHR 0.90, 95% CI 0.68–1.18; p=0.46).

    “PFO was independently associated with increased risks of stroke/TIA and all-cause mortality but not with MI, HF hospitalization, or composite MACE.”

    HumansPatients with obstructive sleep apneaFive years70.5% malesn = 5,963

    Association of Patent Foramen Ovale with Cardiovascular Outcomes and Mortality in Patients with Obstructive Sleep Apnea

    AHA Scientific Sessions 2026 abstract

More on Myocardial infarction

Major adverse cardiovascular events

no changein humans1

1 study
  1. Patent foramen ovale is associated with major adverse cardiovascular events in humans (Patients with obstructive sleep apnea) (aHR 1.07, 95% CI 0.95–1.22; p=0.27).

    “No significant associations were observed between PFO and MACE (aHR 1.07, 95% CI 0.95-1.22; p=0.27)”

    HumansPatients with obstructive sleep apneaFive years70.5% malesn = 5,963

    Association of Patent Foramen Ovale with Cardiovascular Outcomes and Mortality in Patients with Obstructive Sleep Apnea

    AHA Scientific Sessions 2026 abstract

Mortality

upin humans1

1 study
  1. Patent foramen ovale is associated with mortality in humans (Patients with obstructive sleep apnea) (aHR 1.32, 95% CI 1.01–1.71; p=0.04).

    “PFO was independently associated with increased risks of stroke/TIA and all-cause mortality”

    HumansPatients with obstructive sleep apneaFive years70.5% malesn = 5,963

    Association of Patent Foramen Ovale with Cardiovascular Outcomes and Mortality in Patients with Obstructive Sleep Apnea

    AHA Scientific Sessions 2026 abstract

Stroke or transient ischemic attack

upin humans1

1 study
  1. Patent foramen ovale is associated with stroke or transient ischemic attack in humans (Patients with obstructive sleep apnea) (aHR 1.31, 95% CI 1.05–1.63; p=0.02).

    “PFO was independently associated with an increased risk of stroke/TIA”

    HumansPatients with obstructive sleep apneaFive years70.5% malesn = 5,963

    Association of Patent Foramen Ovale with Cardiovascular Outcomes and Mortality in Patients with Obstructive Sleep Apnea

    AHA Scientific Sessions 2026 abstract

More on Stroke or transient ischemic attack

Ischemic stroke prevalence

upin humans1

1 study
  1. Patent foramen ovale is associated with ischemic stroke prevalence in humans (patients with obstructive sleep apnea) (9.04-fold higher stroke prevalence; 95% CI 8.39–9.75).

    “Among 142,465 patients with OSA, the presence of a PFO was associated with a 9.04-fold higher stroke prevalence”

    Humanspatients with obstructive sleep apnean = 142,465

    A Possible Synergistic Association of Obstructive Sleep Apnea and Patent Foramen Ovale on Ischemic Stroke Risk

    AHA Scientific Sessions 2026 abstract

More on Ischemic stroke prevalence

Stroke

upin humans1HR 3.2

1 study
  1. Patent foramen ovale is associated with stroke in humans (Patients with BMI ≥35; patent foramen ovale versus no patent foramen ovale) (5.8% vs 2.4%; HR 3.20, 95% CI 2.45–4.17).

    “a marked increase in stroke risk (5.8% vs 2.4%; HR 3.20, 2.45–4.17; p<0.001)”

    HumansPatients with BMI ≥35; patent foramen ovale versus no patent foramen ovale5 years

    Interplay of patent foramen ovale and severe obesity in long-term thromboembolic and cardiovascular outcomes

    ESC Congress 2026 abstract

More on Stroke

Major adverse cardiovascular and cerebrovascular events

upin humans1HR 1.22

1 study
  1. Patent foramen ovale is associated with major adverse cardiovascular and cerebrovascular events in humans (Patients with BMI ≥35; patent foramen ovale versus no patent foramen ovale) (15.3% vs 9.6%; HR 1.22, 95% CI 1.07–1.40).

    “Conversely, in Analysis B, PFO was associated with higher MACCE (15.3% vs 9.6%; HR 1.22, 1.07–1.40; p=0.003)”

    HumansPatients with BMI ≥35; patent foramen ovale versus no patent foramen ovale5 years

    Interplay of patent foramen ovale and severe obesity in long-term thromboembolic and cardiovascular outcomes

    ESC Congress 2026 abstract

More on Major adverse cardiovascular and cerebrovascular events

All 11

Trial sponsors

Funding

1 grant since 2026

American Heart Association$77K

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 0Mar 2026: 1Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 3Nov 2026: 312 papers in 12 months
ESC Congress 2026 Abstract

Heart defects linked to more complications in artery disease

An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.

Cohort · 35,064 peoplePopulations

See all 17 papers on patent foramen ovale